<DOC>
	<DOCNO>NCT01781455</DOCNO>
	<brief_summary>This open label , single arm dose escalation study BBI503 adult patient advance solid tumor .</brief_summary>
	<brief_title>A Study BBI503 Adult Patients With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<criteria>1 . Signed write informed consent must obtain document accord International Conference Harmonization ( ICH ) Good Clinical Practice ( GCP ) , local regulatory requirement , permission use private health information accordance Health Insurance Portability Accountability Act ( HIPPA ) prior studyspecific screening procedure 2 . A histologically cytologically confirm solid tumor metastatic , unresectable , recurrent standard curative palliative therapy exist longer effective . 3 . ≥ 18 year age 4 . Measurable disease define Response Evaluation Criteria Solid Tumors ( RECIST ) 5 . Karnofsky performance status ≥ 70 % 6 . Male female patient childproducing potential must agree use contraception avoidance pregnancy measure study 30 day last BBI503 dose 7 . Females childbearing potential must negative serum pregnancy test 8 . Aspartate transaminase ( AST ) alanine transaminase ( ALT ) &lt; equal 1.5 × upper limit normal ( ULN ) 9 . Hemoglobin ( Hgb ) ≥ 10 g/dl 10 . Total bilirubin &lt; equal 1.5 × ULN 11 . Creatinine &lt; equal 1.5 x ULN creatinine clearance &gt; 60 mL/min/1.73 m^2 patient creatinine level institutional normal 12 . Absolute neutrophil count &lt; equal 1.5 x 10^9/L 13 . Platelets ≥ 100 x 10^9/L 14 . Life expectancy ≥ 3 month 1 . Anticancer chemotherapy , radiotherapy , immunotherapy , investigational agent within four week first dose exception single dose radiation 8 Gray ( equal 800 RAD ) palliative intent pain control 14 day begin administration BBI503 2 . Surgery within 4 week prior first dose 3 . Any known untreated brain metastasis . Treated subject must stable 4 week completion treatment , image documentation require . Patients must clinical symptom brain metastasis must either steroids stable dose steroid least 2 week prior protocol enrollment . Patients know leptomeningeal metastasis exclude , even treat . 4 . Pregnant breastfeed 5 . Significant gastrointestinal disorder ( ) , opinion Principal Investigator , ( e.g. , Crohn 's disease , ulcerative colitis , extensive gastric resection small intestinal resection ) 6 . Unable unwilling swallow BBI503 capsule daily 7 . Uncontrolled intercurrent illness include , limited ongoing active infection , clinically significant nonhealing heal wound , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , significant pulmonary disease ( shortness breath rest mild exertion ) , uncontrolled infection psychiatric illness/social situation would limit compliance study requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>